Promoting reverse cholesterol transport contributes to the amelioration of atherosclerosis by paeoniflorin
出版年份 2023 全文链接
标题
Promoting reverse cholesterol transport contributes to the amelioration of atherosclerosis by paeoniflorin
作者
关键词
-
出版物
European Journal of Pharmacology
Volume -, Issue -, Pages 176137
出版商
Elsevier BV
发表日期
2023-11-07
DOI
10.1016/j.ejphar.2023.176137
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Paeoniflorin suppresses kidney inflammation by regulating macrophage polarization via KLF4-mediated mitophagy
- (2023) Yiwen Cao et al. PHYTOMEDICINE
- Cholesterol Transport Dysfunction and Its Involvement in Atherogenesis
- (2022) Anastasia V. Poznyak et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Discovery of farnesoid X receptor and its role in bile acid metabolism
- (2022) John Y.L. Chiang et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Activating PGC-1α-mediated signaling cascades in the aorta contributes to the amelioration of vascular senescence and atherosclerosis by 2,3,4′,5-tetrahydroxystilbene-2-O-β-d-glycoside
- (2022) Chun Yan Wang et al. PHYTOMEDICINE
- Different Pathways of Cellular Cholesterol Efflux
- (2022) Alexander D. Dergunov et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Paeoniflorin ameliorates diabetic liver injury by targeting the TXNIP-mediated NLRP3 inflammasome in db/db mice
- (2022) Anli Wang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Isochlorogenic Acid C Alleviates High-Fat Diet-Induced Hyperlipemia by Promoting Cholesterol Reverse Transport
- (2022) Liuyi Zheng et al. Frontiers in Pharmacology
- Recent Insights into the Protective Mechanisms of Paeoniflorin in Neurological, Cardiovascular, and Renal Diseases
- (2021) Feng Jiao et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- ABCA1 and ABCG1 as potential therapeutic targets for the prevention of atherosclerosis
- (2021) Michinori Matsuo JOURNAL OF PHARMACOLOGICAL SCIENCES
- Paeoniflorin, a Natural Product With Multiple Targets in Liver Diseases—A Mini Review
- (2020) Xiao Ma et al. Frontiers in Pharmacology
- Small rodent models of atherosclerosis
- (2020) Yihan Zhao et al. BIOMEDICINE & PHARMACOTHERAPY
- High-Density Lipoprotein Modifications: A Pathological Consequence or Cause of Disease Progression?
- (2020) Andrea Bonnin Márquez et al. Biomedicines
- Polydatin attenuates atherosclerosis in apolipoprotein E-deficient mice: Role of reverse cholesterol transport
- (2019) Yi Peng et al. PHYTOMEDICINE
- Paeoniflorin regulates GALNT2-ANGPTL3-LPL pathway to attenuate dyslipidemia in mice
- (2018) Hong-Bo Xiao et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Beyond the Foam Cell: The Role of LXRs in Preventing Atherogenesis
- (2018) Adil Rasheed et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cholesterol transport system: An integrated cholesterol transport model involved in atherosclerosis
- (2018) Xiao-Hua Yu et al. PROGRESS IN LIPID RESEARCH
- Paeoniflorin Ameliorates Atherosclerosis by Suppressing TLR4-Mediated NF-κB Activation
- (2017) Huan Li et al. INFLAMMATION
- Paeoniflorin Protects against Nonalcoholic Fatty Liver Disease Induced by a High-Fat Diet in Mice
- (2015) Lijing Zhang et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Cholesterol efflux is LXRα isoform-dependent in human macrophages
- (2014) A Zhi Sha Ma et al. BMC Cardiovascular Disorders
- Paeoniflorin acts as a liver X receptor agonist
- (2013) Hsiang-Ru Lin JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH
- Intestinal Specific LXR Activation Stimulates Reverse Cholesterol Transport and Protects from Atherosclerosis
- (2010) Giuseppe Lo Sasso et al. Cell Metabolism
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started